177 related articles for article (PubMed ID: 6435162)
21. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
22. Understanding Washington: a nephrologist's perspective from inside the Beltway.
Rubin RJ
Am J Kidney Dis; 2013 Dec; 62(6):1042-5. PubMed ID: 24051080
[TBL] [Abstract][Full Text] [Related]
23. Lessons for Medicare Part D in the hemodialysis community.
Nayeem AI; Chertow GM
BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
[TBL] [Abstract][Full Text] [Related]
24. Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs.
Lacson E; Ikizler TA; Lazarus JM; Teng M; Hakim RM
J Ren Nutr; 2007 Nov; 17(6):363-71. PubMed ID: 17971308
[TBL] [Abstract][Full Text] [Related]
25. The legislative and regulatory process in the end-stage renal disease (ESRD) program, 1973 through 1997.
Hull AR
Semin Nephrol; 1997 May; 17(3):160-9. PubMed ID: 9165645
[TBL] [Abstract][Full Text] [Related]
26. Medicare program; end-stage renal disease quality incentive program. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2011 Jan; 76(3):627-46. PubMed ID: 21261127
[TBL] [Abstract][Full Text] [Related]
27. Prescription drugs in Medicare and the ESRD program.
Powe NR
Semin Nephrol; 2000 Nov; 20(6):535-42. PubMed ID: 11111855
[TBL] [Abstract][Full Text] [Related]
28. The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients.
Hattori S; Yosioka K; Honda M; Ito H;
Pediatr Nephrol; 2002 Jun; 17(6):456-61. PubMed ID: 12107812
[TBL] [Abstract][Full Text] [Related]
29. The success of medicare's end-stage renal-disease program: the case for profits and the private marketplace.
Lowrie EG; Hampers CL
N Engl J Med; 1981 Aug; 305(8):434-8. PubMed ID: 7019710
[TBL] [Abstract][Full Text] [Related]
30. Disability benefit coverage and program interactions in the working-age population.
Rupp K; Davies PS; Strand A
Soc Secur Bull; 2008; 68(1):1-30. PubMed ID: 18837269
[TBL] [Abstract][Full Text] [Related]
31. Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers.
Schon D; Blume SW; Niebauer K; Hollenbeak CS; de Lissovoy G
Clin J Am Soc Nephrol; 2007 Mar; 2(2):268-76. PubMed ID: 17699424
[TBL] [Abstract][Full Text] [Related]
32. End-stage renal disease and chronic kidney disease in Brazil.
Lugon JR
Ethn Dis; 2009; 19(1 Suppl 1):S1-7-9. PubMed ID: 19484865
[TBL] [Abstract][Full Text] [Related]
33. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance.
Yang WC; Hwang SJ;
Nephrol Dial Transplant; 2008 Dec; 23(12):3977-82. PubMed ID: 18628366
[TBL] [Abstract][Full Text] [Related]
34. The ESRD uninsured matter.
Williams ME
Adv Chronic Kidney Dis; 2007 Jan; 14(1):67-74. PubMed ID: 17200045
[TBL] [Abstract][Full Text] [Related]
35. Medicare program; clarification of resumption of entitlement rules for Medicare patients with end-stage renal disease (ESRD)--HCFA. Final rule.
Fed Regist; 1995 May; 60(88 Pt 1):22533-5. PubMed ID: 10142805
[TBL] [Abstract][Full Text] [Related]
36. The organization of medical care. Lessons from the Medicare end stage renal disease program.
Levinsky NG
N Engl J Med; 1993 Nov; 329(19):1395-9. PubMed ID: 8413437
[No Abstract] [Full Text] [Related]
37. Bundled-rate legislation for Medicare reimbursement for dialysis services: implications for anemia management with ESAs.
Charytan C
Clin J Am Soc Nephrol; 2010 Dec; 5(12):2355-62. PubMed ID: 21071515
[TBL] [Abstract][Full Text] [Related]
38. The American health care system. The End Stage Renal Disease Program.
Iglehart JK
N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
[No Abstract] [Full Text] [Related]
39. Challenges and directions for Medicare ESRD payment policy.
Ray NF; Ross M
Semin Nephrol; 2000 Nov; 20(6):565-76. PubMed ID: 11111858
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of Connecticut patients receiving services for end-stage uremia.
Pearson DA; Stranova TJ; Thompson JD
Public Health Rep; 1975; 90(5):440-8. PubMed ID: 809795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
